esreboxetine has been researched along with maprotiline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Alfinito, P; Bray, JA; Coghlan, RD; Cosmi, SA; Deecher, DC; Heffernan, GD; Huselton, C; Johnston, GH; Kenney, T; Koury, E; Li, Y; Mahaney, PE; Manas, ES; McDevitt, RE; Robichaud, AJ; Trybulski, EJ; Winneker, RC | 1 |
2 other study(ies) available for esreboxetine and maprotiline
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.
Topics: Biological Transport; Cell Line; Humans; Indoles; Neurotransmitter Uptake Inhibitors; Norepinephrine; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Structure-Activity Relationship | 2009 |